The fact the drug only targets a sub unit in IL23 rather than a blanket block means they are closer to finding the cause and just blocking that alone.
Probably cutting down the side effects at the same time. Yes this shows that there is some great research going on and the future for psoriasis sufferers looks brighter
Probably cutting down the side effects at the same time. Yes this shows that there is some great research going on and the future for psoriasis sufferers looks brighter